Apollomics Inc. (APLM)
NASDAQ: APLM
· Real-Time Price · USD
18.43
-0.00 (-0.02%)
At close: Sep 17, 2025, 2:37 PM
-0.02% (1D)
| Bid | 18.43 |
| Market Cap | 20.34M |
| Revenue (ttm) | 2.27M |
| Net Income (ttm) | -57.11M |
| EPS (ttm) | -52.8 |
| PE Ratio (ttm) | -0.35 |
| Forward PE | -0.15 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 18.43 |
| Volume | 682,685 |
| Avg. Volume (20D) | 53,796 |
| Open | 18.43 |
| Previous Close | 18.43 |
| Day's Range | 18.43 - 18.43 |
| 52-Week Range | 3.66 - 36.00 |
| Beta | 0.89 |
| Ex-Dividend Date | n/a |
About APLM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol APLM
Website n/a
5 months ago
-10.58%
Apollomics shares are trading lower. The company r...
Unlock content with
Pro Subscription
5 months ago
-18.53%
Apollomics shares are trading higher after the company announced a development and commercialization agreement for Vebreltinib.
